Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case control study.

Autor: Guarnera L; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.; Department of Translational Hematology & Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, 44114, USA., Tiravanti I; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Guiducci A; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Coppola L; Clinical Infectious Diseases, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy., Marinoni M; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Nunzi A; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Laureana R; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Cardillo L; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Esposito F; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Secchi R; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Buzzatti E; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Paterno G; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.; Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy., Pupo L; Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy., Sarmati L; Clinical Infectious Diseases, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy., Gattei V; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy., Venditti A; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. adriano.venditti@uniroma2.it.; Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy. adriano.venditti@uniroma2.it., Postorino M; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.; Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy., Del Principe MI; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.; Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy.

Publikováno v: Annals of hematology [Ann Hematol] 2024 Sep; Vol. 103 (9), pp. 3831-3833. Date of Electronic Publication: 2024 Jul 19.

CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience.

Autor: Bomben R; Clinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy., Zucchetto A; Clinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy., Laureana R; Division of Haematology University of Tor Vergata Rome Italy., Chiarenza A; Division of Hematology, Policlinico, Department of Surgery and Medical Specialties University of Catania Catania Italy., Olivieri J; Clinica Ematologica, Centro Trapianti e Terapie Cellulari 'Carlo Melzi' DISM Azienda Ospedaliera Universitaria S. Maria Misericordia Udine Italy., Tissino E; Clinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy., Rossi FM; Clinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy., Vit F; Clinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy., Bittolo T; Clinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy., Papotti R; Clinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy., Pozzo F; Clinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy., Gaglio A; Clinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy., Degan M; Clinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy., Polesel J; Unit of Cancer Epidemiology Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy., Marasca R; Hematology Unit, Department of Oncology and Hematology Azienda-Ospedaliero Universitaria (AOU) of Modena, Policlinico Modena Italy.; Department of Medical and Surgical Sciences University of Modena e Reggio Emilia Emilia-Romagna Italy., Visentin A; Hematology unit, Department of Medicine University of Padova Padova Italy., Moia R; Division of Hematology, Department of Translational Medicine Università del Piemonte Orientale Novara Italy., Innocenti I; Fondazione Universitaria Policlinico A Gemelli di Roma Roma Italy., Vitale C; A.O.U. Città della Salute e della Scienza di Torino Torino Italy., Murru R; Hematology and Stem Cell Transplantation Unit, Ospedale A. Businco, ARNAS G. Brotzu Cagliari Italy., Varettoni M; Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy., Tafuri A; Department of Clinical and Molecular Medicine and Hematology, Sant'Andrea - University Hospital - Sapienza University of Rome Rome Italy., Zaja F; Department of Medical, Surgical and Health Sciences University of Trieste Trieste Italy., Postorino M; Division of Haematology University of Tor Vergata Rome Italy., Martino EA; Hematology Unit Azienda Ospedaliera Annunziata Cosenza Italy., Condoluci A; Oncology Institute of Southern Switzerland and Institute of Oncology Research Bellinzona Switzerland., Rossi D; Oncology Institute of Southern Switzerland and Institute of Oncology Research Bellinzona Switzerland., Cuneo A; Hematology Section, Department of Medical Sciences University of Ferrara Ferrara Italy., Di Raimondo F; Division of Hematology, Policlinico, Department of Surgery and Medical Specialties University of Catania Catania Italy., Sportoletti P; Centro di Ricerca Emato-Oncologica (CREO), Dipartimento di Medicina e Chirurgia Università di Perugia Perugia Italy., Del Giudice I; Hematology, Department of Translational and Precision Medicine 'Sapienza' University Rome Italy., Foà R; Hematology, Department of Translational and Precision Medicine 'Sapienza' University Rome Italy., Mauro FR; Hematology, Department of Translational and Precision Medicine 'Sapienza' University Rome Italy., Coscia M; A.O.U. Città della Salute e della Scienza di Torino Torino Italy., Laurenti L; Fondazione Universitaria Policlinico A Gemelli di Roma Roma Italy., Gaidano G; Division of Hematology, Department of Translational Medicine Università del Piemonte Orientale Novara Italy., Trentin L; Hematology unit, Department of Medicine University of Padova Padova Italy., Principe MID; Division of Haematology University of Tor Vergata Rome Italy., Gentile M; Hematology Unit Azienda Ospedaliera Annunziata Cosenza Italy.; Department of Pharmacy, Health and Nutritional Science University of Calabria Rende Italy., Gattei V; Clinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.

Publikováno v: HemaSphere [Hemasphere] 2024 Jul 15; Vol. 8 (7), pp. e128. Date of Electronic Publication: 2024 Jul 15 (Print Publication: 2024).

CT Images in Follicular Lymphoma: Changes after Treatment Are Predictive of Cardiac Toxicity in Patients Treated with Anthracycline-Based or R-B Regimens.

Autor: Esposito F; Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy., Mezzanotte V; Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy., Tesei C; Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy., Luciano A; Department of Diagnostic Imaging and Interventional Radiology, University of Rome Tor Vergata, 00133 Rome, Italy., Gigliotti PE; Department of Diagnostic Imaging and Interventional Radiology, University of Rome Tor Vergata, 00133 Rome, Italy., Nunzi A; Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy., Secchi R; Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy., Angeloni C; Department of Diagnostic Imaging and Interventional Radiology, University of Rome Tor Vergata, 00133 Rome, Italy., Pitaro M; Department of Diagnostic Imaging and Interventional Radiology, University of Rome Tor Vergata, 00133 Rome, Italy., Meconi F; Fondazione Policlinico di Roma Tor Vergata, 00133 Rome, Italy., Cerocchi M; Department of Diagnostic Imaging and Interventional Radiology, University of Rome Tor Vergata, 00133 Rome, Italy., Garaci F; Department of Diagnostic Imaging and Interventional Radiology, University of Rome Tor Vergata, 00133 Rome, Italy., Venditti A; Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy., Postorino M; Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy., Chiocchi M; Department of Diagnostic Imaging and Interventional Radiology, University of Rome Tor Vergata, 00133 Rome, Italy.

Publikováno v: Cancers [Cancers (Basel)] 2024 Jan 29; Vol. 16 (3). Date of Electronic Publication: 2024 Jan 29.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Present and future of kidney replacement therapy in Italy: the perspective from Italian Dialysis and Transplantation Registry (IDTR)

Autor: Nordio, M, Limido, A, Postorino, M, Bolignano, D, Cirillo, M, Conte, F, Di Napoli, A, Fabbian, F, Ferraro, Pm, Gibertoni, D, Lentini, Pl, Reboldi, G

Publikováno v: Journal of nephrology. 33(6)

Incidence of kidney replacement therapy (KRT) stabilizes or declines both in Europe and in the US; however, it is predictable that global prevalence of KRT will double by 2030. In this paper, we focus on the patterns of incidence, mortality, and prev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::350861436353408177ded4d230e3122e
https://pubmed.ncbi.nlm.nih.gov/32445008